Correlation between the alleles polymorphism of CYP2A6 and CYP2B6 and blood concentration of Valproate sodium

谭兰,郁金泰,欧江荣,孙妍萍,宋敬卉,王雁

2009-01-01

Journal of Clinical Neurology

Abstract:Objective: To investigate the correlation between the alleles polymorphism of CYP2A6 and CYP2B6 and blood concentration of Valproate sodium (VPA). Methods: The 165 epilepsy patients received simplex VPA and without dysfunction of liver and kidney were chose in this study. The alleles polymorphism of CYP2A6 in 95 cases and CYP2B6 in 70 cases were detected by polymerase chain reaction (PCR). Fluorescence polarization immunoassay (FPIA) was used to measure the blood concentration of VPA. Results: The frequence of allele CYP2A6 * 4 in 95 cases was 13.2%. The blood concentration of VPA in patients with allele CYP2A6 * 4 [(4. 23 ± 0. 27) mg/ml] was significantly higher than that in patients without allele CYP2A6 * 4[(3. 35 ± 0. 38) mg/ml] (P < 0.05). The frequence of allele CYP2B6 * 6 was 24. 3%. The blood concentration of VPA in patients with allele CYP2B6 * 6 [(4.12 ± 0. 34)mg/ml] was significantly higher than that in patients without allele CYP2B6 * 6 [(3.07 ± 0.28) mg/ml] (P < 0. 05). Conclusions The blood concentration of VPA is affected by the genetic polymorphisms of CYP2A6 or (and) CYP2B6. The dosage of Valproate sodium in patients harboring alleles CYP 2A6 * 4 or/and CYP2B6 * 6 shall be lower than usual to prevent the adverse effect and wasting the medicine resource.